JYYS Granule Mitigates Renal Injury in Clinic and in Spontaneously Hypertensive Rats by Inhibiting NF-B Signaling-Mediated Microinflammation

Table 1

Effects of JYYS granule on NAG, Alb, and β2-MG content in patients with hypertension-induced renal damage.

Indicators	treatment group (n=20)		placebo group (n=20)
	pre-therapy	post-treatment	pre-therapy	post-treatment
NAG (IU/L)	36.91±11.41	25.55±11.01^#@	37.92±12.16	30.77±10.76
Alb (mg/L)	26.47±7.31	20.12±7.68	26.70±7.61	24.38±7.82
β2-MG	0.42±0.10	0.28±0.10^#@	0.43±0.10	0.37±0.10

Abbreviation: NAG (N-acetyl-D-glucosamine), Alb (albumin), and β2-MG (β2-microglobulin). P<0.05, ^#P<0.01 versus pre-therapy in treatment group and placebo group; ^@P<0.05 versus post-treatment in placebo group.